Načítá se...
FDA Emergency Use Authorization: Glass Half Empty?
Recently, the Food and Drug Administration (FDA) issued emergency use authorization (EUA) of convalescent plasma (CP) for the treatment of COVID-19 hospitalized patients based on a non-peer reviewed open label observational study. Issuance of an EUA without a proven randomized control trial (RCT) se...
Uloženo v:
| Vydáno v: | Clin Infect Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7665427/ https://ncbi.nlm.nih.gov/pubmed/33104216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa1653 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|